148 related articles for article (PubMed ID: 6400479)
1. A new era of exploitation of microbial metabolites.
Demain AL
Biochem Soc Symp; 1983; 48():117-32. PubMed ID: 6400479
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
Minsker DH; MacDonald JS; Robertson RT; Bokelman DL
Teratology; 1983 Dec; 28(3):449-56. PubMed ID: 6665743
[TBL] [Abstract][Full Text] [Related]
3. Efficient total synthesis of novel bioactive microbial metabolites.
Sunazuka T; Hirose T; Omura S
Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.
Manzoni M; Rollini M
Appl Microbiol Biotechnol; 2002 Apr; 58(5):555-64. PubMed ID: 11956737
[TBL] [Abstract][Full Text] [Related]
5. Production of microbial secondary metabolites: regulation by the carbon source.
Ruiz B; Chávez A; Forero A; García-Huante Y; Romero A; Sánchez M; Rocha D; Sánchez B; Rodríguez-Sanoja R; Sánchez S; Langley E
Crit Rev Microbiol; 2010 May; 36(2):146-67. PubMed ID: 20210692
[TBL] [Abstract][Full Text] [Related]
6. Fungal secondary metabolism - from biochemistry to genomics.
Keller NP; Turner G; Bennett JW
Nat Rev Microbiol; 2005 Dec; 3(12):937-47. PubMed ID: 16322742
[TBL] [Abstract][Full Text] [Related]
7. The historical delivery of antibiotics from microbial natural products--can history repeat?
Peláez F
Biochem Pharmacol; 2006 Mar; 71(7):981-90. PubMed ID: 16290171
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Advances in drug discovery and biochemical studies.
Kita K; Shiomi K; Omura S
Trends Parasitol; 2007 May; 23(5):223-9. PubMed ID: 17383234
[TBL] [Abstract][Full Text] [Related]
10. [Synthetic biology toward microbial secondary metabolites and pharmaceuticals].
Wu LZ; Hong B
Yao Xue Xue Bao; 2013 Feb; 48(2):155-60. PubMed ID: 23672010
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
12. Production of drugs by microbial biosynthesis and biotransformation. Possibilities, limits and future developments (1st communication).
Kieslich K
Arzneimittelforschung; 1986 Apr; 36(4):774-8. PubMed ID: 3718602
[TBL] [Abstract][Full Text] [Related]
13. Big effects from small changes: possible ways to explore nature's chemical diversity.
Bode HB; Bethe B; Höfs R; Zeeck A
Chembiochem; 2002 Jul; 3(7):619-27. PubMed ID: 12324995
[TBL] [Abstract][Full Text] [Related]
14. Diversifying microbial natural products for drug discovery.
Knight V; Sanglier JJ; DiTullio D; Braccili S; Bonner P; Waters J; Hughes D; Zhang L
Appl Microbiol Biotechnol; 2003 Oct; 62(5-6):446-58. PubMed ID: 12838377
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
16. Monascus rice products.
Wang TH; Lin TF
Adv Food Nutr Res; 2007; 53():123-59. PubMed ID: 17900498
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis, function, and evolutionary origin of secondary metabolites produced by micro-organisms].
Santana C; Segura D; Sánchez S
Rev Latinoam Microbiol; 1994; 36(2):139-58. PubMed ID: 7973181
[TBL] [Abstract][Full Text] [Related]
18. Nontraditional microbial bioactive metabolites.
Bĕhal V
Folia Microbiol (Praha); 2001; 46(5):363-70. PubMed ID: 11899465
[TBL] [Abstract][Full Text] [Related]
19. New bioactive fatty acids.
Hou CT
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():192-5. PubMed ID: 18296335
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics: natural products essential to human health.
Demain AL
Med Res Rev; 2009 Nov; 29(6):821-42. PubMed ID: 19291695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
